For companies with a significant turnover or having completed a first round of seed funding, the 18-month Eurasanté acceleration programme, complementary to the Bio Incubator, allows them to accelerate their development towards Series A fundraising. These companies benefit from Eurasante’s expertise in:
- business development in France and abroad;
- market access;
- financing and series A capital raising;
- managerial and HR aspects (talent recruitment, leadership, internal organization, culture).
Are you planning clinical development and scientific cooperation in France and Europe? Is European marketing a key factor for your company’s growth and development?
Located at a busy crossroad for European businesses, the Eurasanté Bio-Acceleration Program aims to jump start medical startups and companies looking to develop in Europe. Whether you innovate in software, hardware, a service, or a combination of these, our programme will provide you with what you need to tackle the major challenges of the MedTech/Digital Health industry more effectively. Our team of experts and partners will guide you through key topics, such as value propositions, business modelling, reimbursement, IP, regulatory requirements, and much more.